Impact of prompt versus delayed initiation of triple therapy post COPD exacerbation in a US-managed care setting

被引:23
作者
Bogart, Michael [1 ]
Glassberg, Mrudula B. [2 ]
Reinsch, Tyler [1 ,3 ]
Stanford, Richard H. [1 ,3 ]
机构
[1] GSK, 5 Moore Dr, Res Triangle Pk, NC 27709 USA
[2] Ethicon, US Route 22, Somerville, NJ USA
[3] Univ N Carolina, Div Pharmaceut Outcomes & Policy, Chapel Hill, NC 27515 USA
关键词
Chronic obstructive pulmonary disease; Cost; Exacerbations; Inhaled corticosteroids; Long-acting beta(2)-agonists; Long-acting muscarinic antagonists; OBSTRUCTIVE PULMONARY-DISEASE; FLUTICASONE PROPIONATE/SALMETEROL; PROPENSITY SCORE; TIOTROPIUM;
D O I
10.1016/j.rmed.2018.10.013
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: It is unknown whether there is a benefit to initiating triple therapy (TT; inhaled corticosteroids combined with long-acting beta(2)-agonists and long-acting muscarinic antagonists) promptly (within 30 days) following a chronic obstructive pulmonary disease (COPD)-related hospitalization or emergency-department (ED) visit compared with delaying treatment (31-180 days). Methods: This retrospective, observational study (GSK: HO-15-15256) used healthcare claims from a commercial and Medicare claims database (January 1, 2008-December 31, 2015). Patients: >= 40 years of age, diagnosed with COPD and no history of TT 12 months pre-index. Patients experiencing a COPD-related hospitalization or ED visit (index) who initiated TT <= 6 months following index were included (January 1, 2009-December 31, 2014). Patients initiating TT <= 30 or 31-180 days following index were included in the Prompt or Delayed cohorts, respectively. All-cause and COPD-related costs (total, medical and prescription), and exacerbations (severe and moderate) per patient per year were determined for 12 months post index. Outcomes were adjusted by cohort, weighted for a balanced distribution of baseline covariates between cohorts using inverse probability weights. Results: Overall, 10,902 patients were identified (Prompt: n = 5701; Delayed: n = 5201). Total, medical and prescription all- cause costs were significantly higher in the Delayed versus Prompt cohorts (percent increase: 18.7%, 22.8% and 8.8%, respectively; all p < 0.0001). COPD-related total, medical and prescription costs were 49.3%, 66.3% and 10.3% higher in the Delayed versus Prompt cohorts, respectively (all p < 0.0001). Total and severe COPD-related exacerbation rates were 28.2% and 64.7% higher in the Delayed versus Prompt cohorts (p < 0.0001). Conclusion: Prompt use of TT following a COPD-inpatient or ED visit may reduce future costs and subsequent exacerbations compared with delaying the initiation of TT.
引用
收藏
页码:138 / 144
页数:7
相关论文
共 18 条
[1]  
[Anonymous], MORB MORT CHART BOOK
[2]  
[Anonymous], 2018, GLOB STRAT DIAGN MAN
[3]  
[Anonymous], HOW SER IS COPD
[4]  
[Anonymous], PHARM MAN COPD EX
[5]   A Tutorial and Case Study in Propensity Score Analysis: An Application to Estimating the Effect of In-Hospital Smoking Cessation Counseling on Mortality [J].
Austin, Peter C. .
MULTIVARIATE BEHAVIORAL RESEARCH, 2011, 46 (01) :119-151
[6]   A pilot study to assess the effects of combining fluticasone propionate/salmeterol and tiotropium on the airflow obstruction of patients with severe-to-very severe COPD [J].
Cazzola, Mario ;
Ando, Filippo ;
Santus, Pierachille ;
Ruggeri, Paolo ;
Di Marco, Fabiano ;
Sanduzzi, Alessandro ;
D'Amato, Maria .
PULMONARY PHARMACOLOGY & THERAPEUTICS, 2007, 20 (05) :556-561
[7]   COPD exacerbation frequency and its association with health care resource utilization and costs [J].
Dhamane, Amol D. ;
Moretz, Chad ;
Zhou, Yunping ;
Burslem, Kate ;
Saverno, Kim ;
Jain, Gagan ;
Renda, Andrew ;
Kaila, Shuchita .
INTERNATIONAL JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE, 2015, 10 :2609-2618
[8]   The clinical and economic burden of chronic obstructive pulmonary disease in the USA [J].
Guarascio, Anthony J. ;
Ray, Shaunta M. ;
Finch, Christopher K. ;
Self, Timothy H. .
CLINICOECONOMICS AND OUTCOMES RESEARCH, 2013, 5 :235-245
[9]   Optimizing maintenance therapy for, chronic obstructive pulmonary disease: Strategies for improving patient-centered outcomes [J].
Hanania, Nicola A. .
CLINICAL THERAPEUTICS, 2007, 29 (10) :2121-2133
[10]   Once-Daily Single-Inhaler Triple versus Dual Therapy in Patients with COPD [J].
Lipson, David A. ;
Barnhart, Frank ;
Brealey, Noushin ;
Brooks, Jean ;
Criner, Gerard J. ;
Day, Nicola C. ;
Dransfield, Mark T. ;
Halpin, David M. G. ;
Han, MeiLan K. ;
Jones, C. Elaine ;
Kilbride, Sally ;
Lange, Peter ;
Lomas, David A. ;
Martinez, Fernando J. ;
Singh, Dave ;
Tabberer, Maggie ;
Wise, Robert A. ;
Pascoe, Steven J. .
NEW ENGLAND JOURNAL OF MEDICINE, 2018, 378 (18) :1671-1680